Clinical Trial

Optical Biopsy and Cytological Evaluation for Intrathoracic Lymphadenopathy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 2, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to describe and validate confocal laser endomicroscopy(CLE) and rapid on-site evaluation(ROSE) interpretation criteria for different types of intrathoracic lymphadenopathy.
Trial Details
NCT Number NCT07047417
Lead Sponsor Shanghai Chest Hospital
Conditions Intrathoracic Lymphadenopathy
Enrollment 150 participants
Start Date 2025-07-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-02